Transgene Biotek shareholding pattern
TRABI
2.11
0.02 (0.96%)Last updated on 1 Feb, 2026 | 15:29 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Summary
For Year 2025-26, Transgene Biotek reports the following shareholding: Total Promoters at 23.64%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0%, Domestic Institutional Investors at 0%, and Retail at 76.36%. This breakdown provides a quick snapshot of ownership distribution for Transgene Biotek in 2025-26.
Transgene Biotek FAQs
As of 02-2026, the promoter shareholding in Transgene Biotek stands at 23.64% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Transgene Biotek is 0% and 0% respectively.
The retail shareholding of the Transgene Biotek is 76.36%.
Changes in shareholding patterns of Transgene Biotek can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Transgene Biotek are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
